Cargando…

A strategy to reduce illicit drug use is effective in elite Australian football

BACKGROUND: The World Anti-Doping Agency (WADA) prescribes that drug testing is conducted in sports competitions to detect drug use in athletes. This testing includes performance-enhancing drugs as well as illicit substances such as marijuana, amphetamines and cocaine. Illicit drugs are tested for o...

Descripción completa

Detalles Bibliográficos
Autores principales: Harcourt, Peter R, Unglik, Harry, Cook, Jill L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463863/
https://www.ncbi.nlm.nih.gov/pubmed/22893512
http://dx.doi.org/10.1136/bjsports-2012-091329
_version_ 1782245336284135424
author Harcourt, Peter R
Unglik, Harry
Cook, Jill L
author_facet Harcourt, Peter R
Unglik, Harry
Cook, Jill L
author_sort Harcourt, Peter R
collection PubMed
description BACKGROUND: The World Anti-Doping Agency (WADA) prescribes that drug testing is conducted in sports competitions to detect drug use in athletes. This testing includes performance-enhancing drugs as well as illicit substances such as marijuana, amphetamines and cocaine. Illicit drugs are tested for on match days but not on non-match days. Some athletes are known to use illicit substances for recreational purposes, away from competition times and this poses a serious health and welfare issue not addressed by the usual sport drug testing regimes. This paper reports the results of the first 7 years of an illicit drug-testing programme that included non-match day testing in the elite Australian Football competition, the Australian Football League (AFL). METHODS: Players in the AFL were tested for illicit drugs both in-competition and out-of-competition. Players were selected for illicit substance tests either randomly or targeted based on previous test history or time since previous test. The number of tests conducted was increased each year from 2005 to 2011 and testing was focused on high-risk times during non-competition periods. RESULTS: There were no positive match day tests. There was a significant reduction in positive tests (19–6) for illicit drugs during non-competition periods over the 7 years (p<0.0001). The reduction in positive tests may be related to player education, the greater number of tests conducted and the harm minimisation approach of the illicit drug policy. CONCLUSIONS: An illicit drugs programme using a harm minimisation strategy can work effectively alongside a sport's WADA compliant Anti-Doping Code.
format Online
Article
Text
id pubmed-3463863
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-34638632012-10-04 A strategy to reduce illicit drug use is effective in elite Australian football Harcourt, Peter R Unglik, Harry Cook, Jill L Br J Sports Med Original Articles BACKGROUND: The World Anti-Doping Agency (WADA) prescribes that drug testing is conducted in sports competitions to detect drug use in athletes. This testing includes performance-enhancing drugs as well as illicit substances such as marijuana, amphetamines and cocaine. Illicit drugs are tested for on match days but not on non-match days. Some athletes are known to use illicit substances for recreational purposes, away from competition times and this poses a serious health and welfare issue not addressed by the usual sport drug testing regimes. This paper reports the results of the first 7 years of an illicit drug-testing programme that included non-match day testing in the elite Australian Football competition, the Australian Football League (AFL). METHODS: Players in the AFL were tested for illicit drugs both in-competition and out-of-competition. Players were selected for illicit substance tests either randomly or targeted based on previous test history or time since previous test. The number of tests conducted was increased each year from 2005 to 2011 and testing was focused on high-risk times during non-competition periods. RESULTS: There were no positive match day tests. There was a significant reduction in positive tests (19–6) for illicit drugs during non-competition periods over the 7 years (p<0.0001). The reduction in positive tests may be related to player education, the greater number of tests conducted and the harm minimisation approach of the illicit drug policy. CONCLUSIONS: An illicit drugs programme using a harm minimisation strategy can work effectively alongside a sport's WADA compliant Anti-Doping Code. BMJ Group 2012-10 /pmc/articles/PMC3463863/ /pubmed/22893512 http://dx.doi.org/10.1136/bjsports-2012-091329 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode
spellingShingle Original Articles
Harcourt, Peter R
Unglik, Harry
Cook, Jill L
A strategy to reduce illicit drug use is effective in elite Australian football
title A strategy to reduce illicit drug use is effective in elite Australian football
title_full A strategy to reduce illicit drug use is effective in elite Australian football
title_fullStr A strategy to reduce illicit drug use is effective in elite Australian football
title_full_unstemmed A strategy to reduce illicit drug use is effective in elite Australian football
title_short A strategy to reduce illicit drug use is effective in elite Australian football
title_sort strategy to reduce illicit drug use is effective in elite australian football
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463863/
https://www.ncbi.nlm.nih.gov/pubmed/22893512
http://dx.doi.org/10.1136/bjsports-2012-091329
work_keys_str_mv AT harcourtpeterr astrategytoreduceillicitdruguseiseffectiveineliteaustralianfootball
AT unglikharry astrategytoreduceillicitdruguseiseffectiveineliteaustralianfootball
AT cookjilll astrategytoreduceillicitdruguseiseffectiveineliteaustralianfootball
AT harcourtpeterr strategytoreduceillicitdruguseiseffectiveineliteaustralianfootball
AT unglikharry strategytoreduceillicitdruguseiseffectiveineliteaustralianfootball
AT cookjilll strategytoreduceillicitdruguseiseffectiveineliteaustralianfootball